| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/11/2000 | US6087393 Stabilized vitamin C formulations |
| 07/11/2000 | US6087392 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 07/11/2000 | US6087388 Compositions and methods of combatting fungi |
| 07/11/2000 | US6087386 A bilayer or trilayer tablet dose form comprising a first enalapril layer and a second losartan layer for the coadministration of an ace inihibitor with an aii antagonist; treating hypertension and congestive heart failur |
| 07/11/2000 | US6087384 Treating prophylaxis and treatment of a disease associate with death of cells caused by viral diseases, myelodysplasis, neurodegenerative, ischemic and hepatic diseases with a compound having an insulin sensitivity enhancing activity |
| 07/11/2000 | US6087383 A viricide have high solubility/dissolution rate and oral bioavailability |
| 07/11/2000 | US6087382 Administering a combination of l-lysine, minocycline hydrochloride and metronidazole |
| 07/11/2000 | US6087381 Pyrazole derivatives as p38 kinase inhibitors |
| 07/11/2000 | US6087379 Cyclic amine derivatives |
| 07/11/2000 | US6087378 The active benzo(b)thiophene compounds for treating osteoporosis and cardiovascular disorders, especially hyperlipidemia |
| 07/11/2000 | US6087377 Reducing the side effects associated with anticancer drug irinotecan by administering an antiestrogen at least two cell cycles prior to administration of the irinotecan |
| 07/11/2000 | US6087376 Blocking dopamine uptake for treating brain trauma, eating disorders, psychosis, sleep disorders, myasthenia gravis, parkinson's disease, schizophrenia, tourette's syndrome, huntington's disease and attention deficit disorders |
| 07/11/2000 | US6087372 Method of enhancing cognition with 2-(4-methoxyphenyl)-pyrazolo[4,3-c]quinolin-3-one |
| 07/11/2000 | US6087370 Methods of treatment using lamellarin-class alkaloids |
| 07/11/2000 | US6087369 Indole derivatives, process for producing the same and medicinal uses of the same |
| 07/11/2000 | US6087368 Quinazolinone inhibitors of cGMP phosphodiesterase |
| 07/11/2000 | US6087367 Potent inducers of terminal differentiation and methods of use thereof |
| 07/11/2000 | US6087366 Use of flavopiridol or a pharmaceutically acceptable salt thereof for inhibiting cell damage or cell death |
| 07/11/2000 | US6087365 Treating drug-resistant malaria in a mammal |
| 07/11/2000 | US6087363 Blocking the production of nitric oxide (no) by neural cells; administering certain marine-derived compound selected from topsentin, nortopsentin-c, hamacanthin-a, dragmacidin, and dragmacidin-d |
| 07/11/2000 | US6087362 Treating erectile dysfunction in a human patients by administering prior to sexual activity |
| 07/11/2000 | US6087361 Aryl-imidazolines and aryl-imidazoles useful as α-2 adrenergic agonists without cardiovascular side effects |
| 07/11/2000 | US6087360 Method of treating heart failure with endothelin antagonists |
| 07/11/2000 | US6087357 Piperazine derivatives as tachykinin antagonists |
| 07/11/2000 | US6087356 Anesthetizing the patient to produce a state of unconsciousness, administering dextromethorphan to reduce the feelings of withdrawal symptoms, administering an opioid antagonist to induce acute withdrawal |
| 07/11/2000 | US6087355 A therapeutic bactericide composition for treating a methicillin-resistant, vancomycin-resistant, or ampicillin-resistant bacterial infection |
| 07/11/2000 | US6087354 Gallium complexes of 3-hydroxy-4-pyrones to treat cancer |
| 07/11/2000 | US6087352 Administering to a female horses and pigs, to control the estrous cycle so that the timing of fertility may be selected |
| 07/11/2000 | US6087351 Method for reducing adenosine levels with a dehydroepiandrosterone and optionally a ubiquinone |
| 07/11/2000 | US6087350 Use of pretreatment chemicals to enhance efficacy of cytotoxic agents |
| 07/11/2000 | US6087349 Method for blocking neoplastic transformation of cells induced by ras oncogenes |
| 07/11/2000 | US6087348 Treating physiological disorders or psychological disorders with neurokinin 1 (substance p) receptor antagonists; side effect reduction; oral once-a-day medicament |
| 07/11/2000 | US6087347 3-substituted-D-homo-1,3,5(10)-estratriene derivatives |
| 07/11/2000 | US6087344 A pharmaceutical composition for effective drug delivery through skin or exposed tissue of a human |
| 07/11/2000 | US6087340 A physiologically acceptable acidic solution of epirubicin hydrochloride dissolved in a physiologically acceptable solvent; free of freeze drying |
| 07/11/2000 | US6087339 Saccharide derivatives |
| 07/11/2000 | US6087336 Peptide derivatives useful in treating autoimmune diseases |
| 07/11/2000 | US6087304 Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 07/11/2000 | US6087186 Synthetic library of random oligomers, each member comprising an oligomer linked to a microchip encoded with information identifying structure of oligomer; for drug screening |
| 07/11/2000 | US6087173 Antisense modulation of X-linked inhibitor of apoptosis expression |
| 07/11/2000 | US6087172 For treatment of rheumatoid arthritis by suppression of interleukin-15 production |
| 07/11/2000 | US6087169 HKABY60: polynucleotide encoding a helix-loop-helix ubiquitous kinase family polypeptide |
| 07/11/2000 | US6087164 Introducing polynucleotide comprising a regulatory sequence, derived from a genomically imprinted gene specifically expressed in tumor cell, linked to a heterologous sequence encoding cytotoxic product; antitumor agents; gene therapy |
| 07/11/2000 | US6087150 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4 |
| 07/11/2000 | US6087142 Valyl tRNA synthetase from streptococcus pneumoniae |
| 07/11/2000 | US6087122 Polynucleotide sequence which codes a mammalian polypeptide synthetases; for diagnosis, evaluation, prevention, and treatment of physiological defects |
| 07/11/2000 | US6087110 Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein |
| 07/11/2000 | US6087105 Nucleotide sequences coding a protein associated with adherence and infection of bacterial parasite; for detection of modulators of bacterial adhesion |
| 07/11/2000 | US6087092 Dietary fiber and a polyphenol compound which efficiently reduces diarrhea in human and other animals |
| 07/11/2000 | US6086921 Metal/thiol biocides |
| 07/11/2000 | US6086919 Pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound |
| 07/11/2000 | US6086916 Progesterone tablet and its manufacturing process |
| 07/11/2000 | US6086914 Nonsedating formulations for allergic rhinitis which possess antihistaminic and anticholinergic activity |
| 07/11/2000 | US6086911 Flexible backing of nonwoven thermoplastic polymer web, molecular oriented fibers with patterns for drug delivery |
| 07/11/2000 | US6086909 Device and method for treatment of dysmenorrhea |
| 07/11/2000 | US6086907 Coating tissue coating for surgery |
| 07/11/2000 | US6086906 Cyanoacrylate compositions comprising an antimicrobial agent |
| 07/11/2000 | US6086905 Protective barriers for skin to prevent absorption of toxins |
| 07/11/2000 | US6086899 Ethylene oxide-propylene oxide copolymer |
| 07/11/2000 | US6086891 Plasmids |
| 07/11/2000 | US6086889 Process for the isolation of Z and E gugulsterones from aerial branches of Commiphora wightii (guggul) |
| 07/11/2000 | US6086883 Glycolipids and ginkgolic acids |
| 07/11/2000 | US6086874 Kit comprising an interleukin-6 (il-6) antagonist such as antibody to il-6, antibody to il-6 receptor, and antibody to gp130 protein, an antitumor agent such as cisplatin, and a carrier; antagonist and antitumor agent not physically bonded |
| 07/11/2000 | US6086865 O-chloracetylcarbamoylfumagillol and interferon; synergistic angiogenesis inhibitory effect |
| 07/11/2000 | US6086864 Polythioureas having 3 to 50 recurring units derived from aromatic diamines substituted with anionic groups including a sulfonic acid group; water soluble, have a rigid backbone; useful for treatment and diagnosis of aids |
| 07/11/2000 | US6086858 Sunscreen composition with a bright color indicator which contrasts human skin to discern an area covered by the composition and ensuring even coverage, then disappears after distribution on the skin |
| 07/11/2000 | US6086857 Cinnamylidene camphor derivatives and their use as UV-A protecting agents |
| 07/11/2000 | US6086789 Medical uses of pyruvates |
| 07/11/2000 | US6086597 Ophthalmic composition |
| 07/11/2000 | CA2188385C Dosage forms and method for ameliorating male erectile dysfunction |
| 07/11/2000 | CA2174803C Use of liposome encapsulated ciprofloxacin as an immunotherapeutic drug |
| 07/11/2000 | CA2030519C Acryloyl substituted pyrrole derivatives |
| 07/11/2000 | CA2023340C (quinolin-2-ylmethoxy) indoles as inhibitors of the biosynthesis of leukotrienes |
| 07/11/2000 | CA2019231C Novel acetylcholinesterase inhibitors |
| 07/11/2000 | CA2016780C Dihydrospirorenone as an antiandrogen |
| 07/11/2000 | CA1341050C Neurite growth regulatory factors |
| 07/06/2000 | WO2000039716A2 Arylpropenylimidazoles as farnesyl-protein transferase inhibitors |
| 07/06/2000 | WO2000039589A1 Treatment and diagnosis of cancer using inositolphosphoglycans antagonists |
| 07/06/2000 | WO2000039331A1 Single nucleotide polymorphism in a pyruvate dehydrogenase kinase isoenzyme 2 (pdk2) in humans |
| 07/06/2000 | WO2000039327A1 Peptidoglycan recognition proteins |
| 07/06/2000 | WO2000039311A1 Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 |
| 07/06/2000 | WO2000039308A1 Ikk3 kinase |
| 07/06/2000 | WO2000039302A2 Improved expression of hiv polypeptides and production of virus-like particles |
| 07/06/2000 | WO2000039287A2 A. fumigatus acetyl coenzyme-a carboxylase genes and polypeptides and uses thereof |
| 07/06/2000 | WO2000039279A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 07/06/2000 | WO2000039275A2 Multiple shear stress responsive elements (ssre) and methods of use thereof |
| 07/06/2000 | WO2000039249A1 Ume extract having medicinal effects and compositions containing the same |
| 07/06/2000 | WO2000039176A1 Hydrophilic ampholytic polymer |
| 07/06/2000 | WO2000039160A2 Caspase-8 interacting proteins |
| 07/06/2000 | WO2000039158A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/06/2000 | WO2000039157A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/06/2000 | WO2000039148A1 New 7-alpha, 17-alpha-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases |
| 07/06/2000 | WO2000039143A2 Antiviral nucleoside analogues |
| 07/06/2000 | WO2000039142A1 Erythromycin a compounds and process for preparing the same |
| 07/06/2000 | WO2000039141A1 Inositol-containing hexasaccharides, their synthesis and their uses |
| 07/06/2000 | WO2000039139A1 Anti-(retro)viral conjugates of saccharides and acetamidino or guanidino compounds |
| 07/06/2000 | WO2000039136A2 Human brainiac-5 |
| 07/06/2000 | WO2000039131A1 Nitrogen containing heterobicycles as factor xa inhibitors |
| 07/06/2000 | WO2000039130A2 Prenyl transferase inhibitors |
| 07/06/2000 | WO2000039129A1 Immunosuppressive effects of pteridine derivatives |